Subject-Matter Expertise: TechAccel contracts university faculty as consultants for investment due diligence activities and research scoping
Research Capabilities: TechAccel sponsors research at universities to advance and de-risk portfolio technologies
Innovation: TechAccel seeks early-stage innovations and partners with the university to fund research and advance innovation toward commercialization.
Emerging Companies: TechAccel provides equity capital and support to university start-up companies that match our interest areas.
The TechAccel model addresses a structural change in the marketplace – industry majors are consolidating; R&D budgets are decreasing; promising technology is deprioritized and left underdeveloped.
Externalization of innovation advancement to partners like TechAccel is an increasingly critical component of the industry success equation.
We focus on global challenges in plant and animal science with sizeable markets, industry validation, and our unique competency to combine research and commercialization.
With integrated global innovation sourcing, science advancement and acceleration, TechAccel develops assets to their earliest possible commercial milestones – ready for acquisition to take to market or return to a strategic portfolio.
Deal structure and exit scenarios offer flexibility and maximize return for our partners and investors.
TechAccel invests in start-up companies where we can add scientific and strategic value. Start-up firms can leverage the deep expertise of our team, as well as our network of research institutions, subject-matter experts, and go-to-market partners to deliver accelerated solutions at scale.
Although TechAccel is not structured as a Fund, our model leverages equity investments in high-potential agriculture, animal health, food tech start-ups to deploy and advance the start-up platform in adjacent opportunities.
VCs like investing alongside TechAccel for our deeply experienced multidisciplinary diligence, and our credibility as the science advancement partner.
When TechAccel invests in an agtech or animal health platform technology, we fund the advancement that brings the platform to viability in markets adjacent to the core business, providing new revenue potential for all involved. Deal structure and exit scenarios offer flexibility for partners and investors.
Our science advancement approach, with stage gate project management, maximizes VC investments.
